A2GOLD COMPLETES 4,400-METRE DRILL PROGRAM AT TAYLOR AND MOBILIZES RIG TO EASTSIDE TARGET PENTE

English

TONOPAH, Nev., Sept. 8, 2026 /PRNewswire/ -- A2Gold Corp. ("A2Gold" or the "Company") (TSXV: AUAU) (OTCQX: AUXXF) (FRA: RR7) is pleased to announce the completion of its 2026 drill program at the Taylor Gold-Silver Project ("Taylor" or the "Project") in White Pine County, Nevada. The Company completed 15 reverse-circulation ("RC") drill holes totaling approximately 4,400 metres.

With drilling now completed at Taylor, the drill rig is being mobilized to the Company's flagship Eastside Project near Tonopah, Nevada, where the Company expects to commence an approximately 3,700-metre RC drill program at Target Pente.

Taylor Drill Program Completed

The recently completed program represents A2Gold's first drill campaign at Taylor since acquiring the Project earlier this year. The program was designed to test priority targets identified through the integration of historical drilling, geological information and geophysical data (Figure 1).

A total of 15 RC holes were completed for approximately 4,400 metres. Samples from the drill program have been submitted for laboratory analysis, with assay results pending. The Company expects to report results as they are received, reviewed and interpreted.

In addition to testing the primary drill targets, the program will provide A2Gold with important new geological information to further refine its understanding of the broader mineralized system at Taylor and assist in planning future exploration programs.

Drilling to Commence at Target Pente (Eastside Project)

Following completion of the Taylor program, the drill rig is now being mobilized to A2Gold's flagship Eastside Project, where drilling at Target Pente is expected to commence shortly.

The planned program will consist of approximately 3,700 metres of RC drilling and represents the next phase of A2Gold's 2026 exploration program at Eastside.

Target Pente is one of several high-priority exploration targets identified across the Company's extensive Eastside land package. The program is designed to test the potential for higher-grade epithermal feeder faults and veins, consistent with A2Gold's strategy of targeting higher-grade mineralization within the broader Eastside district rather than simply expanding the known bulk-tonnage mineralized system.

The Company believes that Eastside's large alteration footprint, multiple known centers of mineralization and extensive areas that remain underexplored provide significant opportunities for additional discoveries.

Peter Gianulis, CEO of A2Gold, commented: "The completion of approximately 4,400 metres across 15 holes at Taylor represents an important milestone for A2Gold and our first drill program at the Project since completing the acquisition earlier this year. We look forward to receiving the assay results and incorporating this new information into our understanding of the broader Taylor mineralized system. Importantly, our exploration program continues without interruption. The rig is now being mobilized directly to Eastside to begin drilling Target Pente. Our strategy at Eastside is increasingly focused on testing higher-grade feeder fault and vein targets within this very large epithermal system. Pente represents the next of these targets to be drill tested as we systematically evaluate the broader potential of the Eastside district."

Qualified Person

John Marma, CPG, a Certified Professional Geologist with the American Institute of Professional Geologists and a Qualified Person as defined by National Instrument 43-101, has reviewed and approved the scientific and technical information contained in this news release.

About A2Gold Corp

A2Gold Corp. has built a multi-asset gold-silver exploration platform in Nevada, one of the world's premier mining jurisdictions. The Company controls approximately 230 km² of prospective mineral tenure across its Eastside and Taylor projects, both district-scale assets with large precious metals resources with significant exploration and resource growth potential.

Eastside hosts an inferred mineral resource of 1.4 million ounces of gold and 8.8 million ounces of silver*, while Taylor adds a highly prospective exploration district with gold, silver, antimony and porphyry-skarn upside. Backed by a fully funded exploration program and a strong pipeline of catalysts, A2Gold is focused on unlocking value through resource expansion, new discoveries and systematic district-scale exploration.

A2Gold is also supported by a strong shareholder base, including Kinross Gold Corporation, which owns approximately 9.9% of the Company's issued and outstanding shares.

On Behalf of the Board

Peter Gianulis, CEO

Certain statements and information contained in this press release constitute "forward-looking statements" within the meaning of applicable U.S. securities laws and "forward-looking information" within the meaning of applicable Canadian securities laws, which are referred to collectively as "forward-looking statements." The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements.

Forward-looking statements in this news release include, but are not limited to, statements regarding A2Gold's exploration plans for the Taylor Project, the scope, timing and objectives of the drill program at Taylor, the potential expansion of the historical silver resource, the preparation of an updated NI 43-101 mineral resource estimate, the evaluation of gold mineralization, the testing of gold-antimony, CRD, skarn and porphyry targets, the potential contribution of gold and antimony mineralization to the broader Taylor system, the potential for Taylor to emerge as an important Nevada silver-gold project with critical mineral upside, and A2Gold's future exploration and development plans.

Forward-looking statements are statements and information regarding possible events, conditions or results of operations that are based upon assumptions about future economic conditions and courses of action. All statements and information other than statements of historical fact may be forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as "seek," "expect," "anticipate," "budget," "plan," "estimate," "continue," "forecast," "intend," "believe," "predict," "potential," "target," "may," "could," "would," "might," "will" and similar words or phrases, including negative variations, suggesting future outcomes or statements regarding an outlook.

Such forward-looking statements are based on a number of material factors and assumptions and involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or industry results, to differ materially from those anticipated in such forward-looking information. You are cautioned not to place undue reliance on forward-looking statements contained in this press release.

Some of the known risks and other factors which could cause actual results to differ materially from those expressed in the forward-looking statements are described in the sections entitled "Risk Factors" in A2Gold's Listing Application, dated January 24, 2018, as filed with the TSX Venture Exchange and available on SEDAR+ under A2Gold's profile. Actual results and future events could differ materially from those anticipated in such statements. A2Gold undertakes no obligation to update or revise any forward-looking statements included in this press release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

SOURCE A2 Gold Corp

Share this article

DENVER, Sept. 8, 2026 /PRNewswire/ -- NCS Analytics engaged Armanino LLP, an independent certified public accounting firm, to perform agreed-upon procedures related to certain aspects of NCS Analytics' validation of NCS Thea, a lending intelligence platform designed specifically for financial institutions, private lenders, credit funds, and other organizations providing capital to licensed cannabis businesses.

Armanino LLP performed the agreed-upon procedures and reported its factual findings in accordance with attestation standards established by the American Institute of Certified Public Accountants. Those procedures were performed over certain specific elements of the model's data inputs, application of NCS's scoring methodology, calculation of certain scoring components of Thea's Risk Lending Scores, the assignment of risk classifications, and presentation of the model's outputs.

"Cannabis lenders need objective, reliable intelligence to make informed decisions," said Adam Crabtree, Founder and CEO of NCS Analytics. "This independent engagement reflects our commitment to transparency and rigor in the development and validation of NCS Thea, providing additional confidence in key aspects of the model's methodology and outputs."

NCS Thea was developed because cannabis lending creates unique challenges that traditional underwriting tools were never designed to address. Financial statements are often inconsistent, conventional credit data is limited, and the industry's regulatory complexity makes it difficult to validate borrower performance.

NCS Thea tackles these challenges by combining government-verified operational data from state cannabis track-and-trace systems with NCS Analytics' proprietary behavioral and predictive analytics to provide an objective, independent assessment of business health and lending risk.

"This AUP engagement is not a checkbox. It is the foundation for responsible deployment. By subjecting NCS Thea to external scrutiny, we have confirmed its readiness to support risk decisions with confidence and accountability," said Paige Reimers, COO of NCS Analytics.

About NCS Analytics

NCS Analytics, founded in 2015 in Denver, Colorado, is a leading advanced analytics company that empowers regulators and financial institutions to oversee high-risk industries—starting with cannabis—through its NCS Platform. This SaaS solution aggregates millions of daily data points, delivering real-time anomaly detection, risk scoring, alerts, and compliance monitoring to prevent diversion, fraud, and non-compliance while supporting BSA/AML requirements. NCS Analytics monitors thousands of licenses across multiple states, processes 89M+ records weekly, and launched its newest analytic tool, the Risk Index, in 2025. Discover how NCS empowers real-time critical decision-making with absolute confidence at ncsanalytics.com.

SOURCE NCS Analytics

Share this article

Quantinuum besiegelt CHIPS-F&E-Förderung über 100 Millionen US-Dollar mit dem US-Handelsministerium zur Weiterentwicklung der Herstellung von Quantencomputern mit gefangenen Ionen in den USA

- Die Bundesmittel dienen der Förderung wichtiger Forschungs- und Entwicklungsvorhaben sowie des Aufbaus von Fertigungskapazitäten für Quantenhalbleiter in den USA, die für die Skalierung des fehlertoleranten Quantencomputings mit gefangenen Ionen erforderlich sind.

- Das Unternehmen arbeitet mit GlobalFoundries zusammen, um Ionenfallen und Steuerelektronik der nächsten Generation herzustellen, sowie mit Monarch Quantum, um zuverlässige Laser und optische Komponenten zu entwickeln und zu fertigen.

WASHINGTON, 8. September 2026 /PRNewswire/ -- Quantinuum (Nasdaq: QNT), ein führendes Unternehmen im Bereich Quantencomputing, gab heute bekannt, dass es eine Vereinbarung mit dem CHIPS-Forschungs- und Entwicklungsbüro des US-Handelsministeriums über Bundesmittel in Höhe von 100 Millionen US-Dollar abgeschlossen hat, die im Rahmen des CHIPS and Science Act bereitgestellt werden. Die Förderung, die auf eine im Mai bekannt gegebene Absichtserklärung folgt, unterstützt Forschung und Entwicklung sowie Fertigungskapazitäten für Quantenhalbleiter in den USA, die für den Einsatz großskaliger, fehlertoleranter Quantencomputer mit gefangenen Ionen erforderlich sind.

Quantinuum, das als einziges Unternehmen mit einer auf gefangenen Ionen basierenden Architektur Fördermittel aus dem CHIPS-Forschungs- und Entwicklungsprogramm erhielt, entwickelt die weltweit präzisesten kommerziellen[1] Computer mit branchenführender Fehlerkorrekturgüte.2 Das Unternehmen nutzt etablierte Halbleiterfertigungsverfahren, um dazu beizutragen, die Zuverlässigkeit, Wiederholbarkeit und Skalierbarkeit seiner aktuellen und zukünftigen Quantencomputer sicherzustellen.

„Diese Förderung ist eine Bestätigung der führenden Rolle von Quantinuum im Bereich des Quantencomputings mit gefangenen Ionen", sagte Dr. Rajeeb Hazra, Präsident und Geschäftsführer von Quantinuum. „Gemeinsam mit unseren inländischen Partnern schaffen wir die technologische sowie die Lieferkettengrundlage, die erforderlich sind, um fehlertolerante Systeme zu skalieren und die Führungsrolle der USA in diesem strategisch wichtigen Bereich zu stärken."

Mit dieser Förderung werden Forschungs- und Entwicklungsvorhaben unterstützt, von denen das Unternehmen erwartet, dass sie zur Stärkung sowie Diversifizierung seiner Lieferkette beitragen, indem die inländischen Partner GlobalFoundries und Monarch Quantum hinzukommen. GlobalFoundries wird einer von mehreren Halbleiterfertigern sein, die Quantinuum mit der Fertigung seiner Ionenfallen der nächsten Generation und anderer elektronischer Bauteile beauftragt, wobei der Schwerpunkt insbesondere auf dem Einsatz der 300-mm-Wafer-Technologie liegt; Monarch Quantum plant die Entwicklung und Herstellung skalierbarer, zuverlässiger Laser sowie optischer Komponenten, die für die Systeme mit gefangenen Ionen von Quantinuum benötigt werden.

„Da sich die Quantencomputertechnik immer mehr dem kommerziellen Einsatz nähert, wird die Fertigung entscheidend sein, um ihr volles Potenzial auszuschöpfen", sagte Tim Breen, Geschäftsführer von GlobalFoundries. „GlobalFoundries ist stolz darauf, mit Quantinuum zusammenzuarbeiten, um das Unternehmen bei der Skalierung seiner Technologie mit gefangenen Ionen zu unterstützen. Mit unserem Know-how in der differenzierten Halbleiterfertigung in hohen Stückzahlen tragen wir dazu bei, den Weg für skalierbarere sowie zuverlässigere Quantenhardware zu ebnen und die nächste Generation amerikanischer Innovationen voranzutreiben."

„Der Weg zu groß angelegten Quantencomputern mit gefangenen Ionen führt über den Übergang von komplexen, umfangreichen optischen Aufbauten hin zu skalierbaren, zuverlässigen integrierten Photonik-Modulen", sagte Dr. Timothy Day, Geschäftsführer von Monarch Quantum. „Es ist uns eine Ehre, unsere Partnerschaft mit Quantinuum auszubauen, um die Hardware-Roadmap des Unternehmens voranzutreiben und dazu beizutragen, die Führungsrolle der USA bei der Fertigung im Bereich Quantencomputing sowie bei der Widerstandsfähigkeit der Lieferkette zu stärken."

Gemeinsam sollen diese Bemühungen dazu beitragen, die Komplexität des Systems zu verringern sowie die Robustheit, Zuverlässigkeit und Reproduzierbarkeit der Komponenten zu verbessern, um letztlich die weitere Skalierung von Quantencomputern mit gefangenen Ionen zu unterstützen sowie gleichzeitig die inländischen Kapazitäten in der kritischen Photonik- und Halbleiterfertigung zu stärken.

Informationen zu Quantinuum

Quantinuum ist ein führendes Unternehmen im Bereich Quantencomputing, das eine Full-Stack-Plattform anbietet, die darauf ausgelegt ist, Quantencomputing in realen Umgebungen einsetzbar zu machen. Das Unternehmen hat mehrere Generationen von Quantensystemen auf Basis gefangener Ionen kommerziell eingesetzt, die auf der bewährten QCCD-Architektur aufbauen, welche es mit neuartigen Designs und Funktionen umgesetzt hat, um die branchenweit höchsten Genauigkeitswerte gemessen an der durchschnittlichen Zwei-Qubit-Gattertreue zu erreichen.[3] Quantinuum unterhält aktive Kooperationen sowohl mit Marktführern in den Bereichen Pharmazie, Materialwissenschaften und Finanzdienstleistungen sowie auf Regierungs- und Industriemärkten als auch mit akademischen und Forschungseinrichtungen weltweit. Das Unternehmen hat weltweit über 800 Beschäftigte, darunter führende Wissenschaftler und Forscher. Quantinuum hat seinen Hauptsitz in Broomfield, Colorado, und verfügt über weitere Standorte in den Vereinigten Staaten, im Vereinigten Königreich, in Deutschland, Japan, Katar sowie Singapur. Weitere Informationen finden Sie auf www.quantinuum.com.

Warnhinweis zu zukunftsgerichteten Aussagen

Diese Pressemitteilung enthält bestimmte Aussagen, die als „zukunftsgerichtete Aussagen" im Sinne des Private Securities Litigation Reform Act von 1995 angesehen werden können. Zukunftsgerichtete Aussagen umfassen alle Aussagen, die keine historischen Tatsachen darstellen. Die Begriffe „voraussehen", „annehmen", „glauben", „fortsetzen", „könnte", „schätzen", „erwarten", „beabsichtigen", „kann", „planen", „potenziell", „vorhersagen", „prognostizieren", „zukünftig", „wird", „anstreben", „vorhersehbar" sowie die Verneinungen dieser Begriffe oder ähnliche Ausdrücke sollen zukunftsgerichtete Aussagen kennzeichnen. Solche Aussagen basieren auf bestimmten Annahmen sowie Einschätzungen, die unser Management unter Berücksichtigung seiner Erfahrung und Wahrnehmung historischer Trends, der aktuellen Wirtschafts- und Branchenlage, erwarteter zukünftiger Entwicklungen sowie anderer Faktoren vornimmt, die es für angemessen hält. Die in dieser Mitteilung enthaltenen zukunftsgerichteten Aussagen unterliegen zudem einer Reihe wesentlicher Risiken und Ungewissheiten, einschließlich, aber nicht beschränkt auf wirtschaftliche, wettbewerbsbezogene, staatliche sowie technologische Faktoren, die unsere Geschäftstätigkeit, Märkte, Produkte, Dienstleistungen und Preise beeinflussen. Von Zeit zu Zeit treten neue Faktoren auf und es ist Quantinuum nicht möglich, alle derartigen Faktoren vorherzusagen. Weitere Informationen zu diesen und anderen Risiken, die sich auf die zukunftsgerichteten Aussagen von Quantinuum auswirken könnten, finden Sie in den Risikofaktoren von Quantinuum, die in seinen Einreichungen bei der U.S. Securities and Exchange Commission erörtert werden, einschließlich seines Quartalsberichts auf Formular 10-Q für den am 30. Juni 2026 endenden Zeitraum, wobei diese Risikofaktoren von Zeit zu Zeit aktualisiert werden können. Jede zukunftsgerichtete Aussage gilt nur zu dem Zeitpunkt, zu dem sie abgegeben wird, und Quantinuum übernimmt, sofern nicht gesetzlich vorgeschrieben, keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren oder zu revidieren, sei es aufgrund neuer Informationen, zukünftiger Ereignisse oder aus anderen Gründen.

[1] Basierend auf der physikalischen Zwei-Qubit-Gattertreue zum 31. Dezember 2025, gemäß der Studie von Ransford et al. aus dem Jahr 2025.

[2] Stand: 25. Februar 2026, gemäß der Studie von Dasu et al. aus dem Jahr 2026.

[3] Stand: 31. Dezember 2025.

Share this article

Quantinuum finaliza un acuerdo de financiación de 100 millones de dólares del programa CHIPS para I+D

Quantinuum finaliza un acuerdo de financiación de 100 millones de dólares del programa CHIPS para I+D con el Departamento de Comercio de EE.UU. para impulsar la fabricación de ordenadores cuánticos de iones atrapados en EE.UU.

- La financiación federal respalda las capacidades críticas de I+D y fabricación de semiconductores cuánticos en EE.UU., necesarias para escalar la computación cuántica de iones atrapados tolerante a fallos.

- La empresa se asocia con GlobalFoundries para fabricar trampas de iones y electrónica de control de última generación, y con Monarch Quantum para desarrollar y fabricar láseres y componentes ópticos fiables.

WASHINGTON, 8 de septiembre de 2026 /PRNewswire/ -- Quantinuum (Nasdaq: QNT), una empresa líder en computación cuántica anunció hoy la finalización de un acuerdo con la Oficina de Investigación y Desarrollo CHIPS del Departamento de Comercio de EE.UU. para obtener 100 millones de dólares en fondos federales, gestionados a través de la Ley CHIPS y de Ciencia. Esta subvención, que se produce tras una carta de intención anunciada en mayo, apoya la investigación y el desarrollo, así como las capacidades de fabricación de semiconductores cuánticos en EE.UU., necesarias para el despliegue de ordenadores cuánticos de iones atrapados a gran escala y tolerantes a fallos.

Quantinuum, la única empresa con una arquitectura basada en iones atrapados que recibió financiación de CHIPS para I+D, desarrolla los ordenadores comerciales más precisos del mundo[1] con una fidelidad de corrección de errores líder en la industria.[2] La empresa aprovecha los procesos de fabricación de semiconductores ya establecidos para garantizar la fiabilidad, la repetibilidad y la escalabilidad de sus ordenadores cuánticos actuales y futuros.

"Este premio valida el liderazgo de Quantinuum en la computación cuántica de iones atrapados", declaró el Dr. Rajeeb Hazra, presidente y consejero delegado de Quantinuum. "Junto con nuestros socios nacionales, estamos construyendo la base tecnológica y de la cadena de suministro necesaria para escalar los sistemas tolerantes a fallos y fortalecer el liderazgo de Estados Unidos en este campo de importancia estratégica".

El premio respaldará la I+D que la empresa espera que contribuya a fortalecer y diversificar su cadena de suministro, incorporando a sus socios locales GlobalFoundries y Monarch Quantum. GlobalFoundries será una de las fundiciones de Quantinuum que fabricará sus trampas de iones de próxima generación y otros componentes electrónicos, centrándose específicamente en el uso de tecnología de obleas de 300 mm; Monarch Quantum planea desarrollar y fabricar láseres y componentes ópticos escalables y fiables necesarios para los sistemas de iones atrapados de Quantinuum.

"A medida que la computación cuántica se acerca a la escala comercial, la fabricación será fundamental para liberar todo su potencial", afirmó Tim Breen, consejero delegado de GlobalFoundries. "En GlobalFoundries nos enorgullece asociarnos con Quantinuum para ayudar a escalar su tecnología de iones atrapados. Al aportar nuestra experiencia en la fabricación de semiconductores diferenciados y de alto volumen, estamos contribuyendo a crear un camino hacia un hardware cuántico más escalable y fiable, e impulsando la próxima generación de innovación estadounidense".

"El camino hacia las computadoras cuánticas de iones atrapados a gran escala depende de abandonar las complejas y extensas configuraciones ópticas y adoptar motores fotónicos integrados, escalables y fiables", afirmó el Dr. Timothy Day, consejero delegado de Monarch Quantum. "Nos sentimos honrados de ampliar nuestra colaboración con Quantinuum para impulsar su hoja de ruta de hardware y contribuir a fortalecer el liderazgo de Estados Unidos en la fabricación de computación cuántica y la resiliencia de la cadena de suministro".

En conjunto, estos esfuerzos buscan reducir la complejidad del sistema y mejorar la robustez, la fiabilidad y la reproducibilidad de los componentes, lo que, en última instancia, respalda la continua expansión de las computadoras cuánticas de iones atrapados y fortalece la capacidad nacional en la fabricación de semiconductores y fotónica, sectores críticos para la industria.

Acerca de Quantinuum

Quantinuum es una empresa líder en computación cuántica que ofrece una plataforma integral diseñada para implementar la computación cuántica en entornos reales. La empresa ha implementado comercialmente varias generaciones de sistemas cuánticos basados en iones atrapados, construidos sobre la consolidada arquitectura QCCD, la cual ha incorporado diseños y capacidades innovadoras para alcanzar los niveles de precisión más altos de la industria, basados en la fidelidad promedio de puerta de dos cúbits[3]. Quantinuum mantiene una colaboración activa con líderes del mercado en los sectores farmacéutico, de ciencia de materiales, servicios financieros, gobierno e industria, así como con instituciones académicas y de investigación a nivel mundial. La empresa cuenta con una plantilla global de aproximadamente 800 empleados, incluyendo científicos e investigadores de primer nivel. La sede central de Quantinuum se encuentra en Broomfield, Colorado, y cuenta con instalaciones adicionales en Estados Unidos, Reino Unido, Alemania, Japón, Qatar y Singapur. Para obtener más información, visite www.quantinuum.com.

Declaraciones prospectivas

Este comunicado de prensa contiene ciertas declaraciones que pueden considerarse "declaraciones prospectivas" según lo estipulado en la Ley de Reforma de Litigios sobre Valores Privados de 1995. Las declaraciones prospectivas incluyen todas aquellas que no son hechos históricos. Las palabras "anticipar", "asumir", "creer", "continuar", "podría", "estimar", "esperar", "pretender", "puede", "planificar", "potencial", "predecir", "proyectar", "futuro", "hará", "buscar", "previsible", sus formas negativas o términos y frases similares tienen como objetivo identificar las declaraciones prospectivas. Dichas declaraciones se basan en ciertas suposiciones y evaluaciones realizadas por nuestra gerencia a la luz de su experiencia y su percepción de las tendencias históricas, las condiciones económicas y de la industria actuales, los desarrollos futuros esperados y otros factores que consideran apropiados. Las declaraciones prospectivas incluidas en este comunicado también están sujetas a una serie de riesgos e incertidumbres importantes, que incluyen, entre otros, factores económicos, competitivos, gubernamentales y tecnológicos que afectan nuestras operaciones, mercados, productos, servicios y precios. De vez en cuando surgen nuevos factores, y Quantinuum no puede predecir todos ellos. Para obtener información adicional sobre estos y otros riesgos que podrían afectar las declaraciones prospectivas de Quantinuum, consulte los factores de riesgo de Quantinuum que se describen en sus informes presentados ante la Comisión de Bolsa y Valores de EE.UU., incluido su Informe Trimestral en el Formulario 10-Q para el período finalizado el 30 de junio de 2026, ya que dichos factores de riesgo pueden actualizarse periódicamente. Cualquier declaración prospectiva se refiere únicamente a la fecha en que se realiza y, salvo que lo exija la ley, Quantinuum no asume ninguna obligación de actualizar o revisar ninguna declaración prospectiva, ya sea como resultado de nueva información, eventos futuros o de cualquier otra índole.

[1] Basado en la fidelidad de la puerta física de dos cúbits a 31 de diciembre de 2025, según el estudio 2025 Ransford et al..

[2] A 25 de febrero de 2026, según e estudio 2026 Dasu et al..

[3] A 31 de diciembre de 2025.

Share this article

Leadership transition puts proven operator Geri Farr at the helm while allowing Kortas to focus on growth, innovation and NEXA's highest earned level of leadership

PHOENIX, Sept. 8, 2026 /PRNewswire/ -- NEXA Lending today announced that Geri Farr has been named Chief Executive Officer, marking the next evolution of a leadership structure designed to separate the responsibility of operating the company from the responsibility of imagining what the company becomes next.

Mike Kortas will transition from CEO into the role of Executive Partner, NEXA's highest earned level of leadership.

For Kortas, the move is not about stepping away from NEXA. It is about stepping fully into the role he has been playing all along.

"I have never cared about being called CEO, I care about growth, I care about winning, and most importantly, I care about finding new ways for our loan officers to make more money," Kortas said. "Geri is better equipped to run this company day to day than I am, and my ego is not big enough to pretend otherwise. The best thing I can do for our loan officers is put the right person in the CEO seat and go spend my time creating what comes next."

The relationship between Farr and Kortas reaches back nearly two decades. Long before Farr joined NEXA, and long before Kortas built the company into the organization it is today, Farr was his manager at NOVA Home Loans.

Now, the relationship has come full circle.

"I knew Mike before NEXA, I knew him before the scale, before the platform and before the thousands of loan officers," Farr said. "What has never changed is how his mind works. He sees opportunities other people do not see, and once he sees one, he becomes relentless about making it real. My responsibility as CEO is to make sure NEXA has the leadership, discipline, infrastructure and execution necessary to support where Mike and our Executive Partners want to take us next."

Farr continued, "Putting Mike behind a desk managing the day-to-day business is simply not the highest and best use of Mike Kortas. Let him build, let him challenge assumptions, let him chase the ideas everyone else says are impossible. My job is to make sure the organization can execute when those ideas become reality."

A CEO Built for NEXA's Next Chapter

Farr joined NEXA in 2025 after a career spent leading organizations through growth, transition and scale. Her experience across wholesale and distributed retail gives her a perspective that aligns directly with NEXA's continued evolution and its mission to create better economics, greater optionality and more opportunity for loan officers.

Her elevation to CEO also reflects the leadership team NEXA has intentionally assembled around her. Chief Administrative Officer Rana Mortensen, NEXA's first employee, has spent the past year working closely alongside Farr and remains one of the organization's most cherished leaders. Chief Operating Officer Jason duPont, who was elevated into NEXA's C-suite in 2025 after years inside the organization, continues to lead operations, as well as one of our Executive Partners alongside Mike. Chief Strategy Officer Tammy Richards shares a longstanding professional relationship with Farr that predates their time at NEXA, while Chief Financial Officer Von Maharaj joined the organization following a rigorous due diligence process in which Farr played an important role.

Together, the structure gives Farr an experienced executive team responsible for operating NEXA while creating something equally important above it: room for NEXA's Executive Partners to think beyond the day-to-day business.

Executive Partner Is Earned

At NEXA, Executive Partner is not another C-suite title, it is intentionally bigger than one.

Executive Partners are proven builders who have earned the ability to help shape the future of the organization. They work alongside the executive leadership team, develop new business concepts, identify acquisitions and partnerships, challenge existing models and create new opportunities designed to increase the economics available to NEXA loan officers.

That distinction is central to Kortas' decision.

"Too many founders build companies around themselves because they are afraid that giving up a title means giving up importance," Kortas said. "That is ego. If I tell loan officers every day to make decisions based on what is best for their business, then I have to be willing to do exactly the same thing. Geri becoming CEO makes NEXA stronger, and me focusing on the Executive Partner role and those who serve it alongside me makes NEXA stronger. That is the only scoreboard I care about."

Executive Partner Anthony Casa believes the structure represents something larger than a traditional corporate hierarchy.

"The Executive Partner role is powerful because you are not being asked to spend your life managing the machinery," Casa said. "You are being asked to help build the future. Mike and I can be in the market, talking to loan officers, talking to mortgage company owners, looking for opportunities, challenging each other and coming up with ideas that can materially change the economics of this business. Then you have an incredible CEO and executive team capable of turning those ideas into reality. That is a very different way to build a mortgage company."

A Different Path for Mortgage Company Owners

NEXA believes that structure can also become a model for other successful mortgage company owners.

For decades, owners have often faced two choices: continue carrying the operational burden of running an independent mortgage company or sell, merge or transition into another organization and risk losing their identity, influence and economic opportunity.

NEXA is building a third option; proven owners and leaders can potentially earn their way into the Executive Partner structure, allowing them to relinquish much of the day-to-day operational burden while continuing to recruit, innovate, build teams, create businesses and influence the future of one of the largest mortgage organizations in the country.

"It should not be considered a loss when an entrepreneur gets to stop worrying about every operational detail and starts spending more time doing the things that made them exceptional in the first place," Kortas said. "Imagine what some of the best mortgage owners in America could create if they did not have to spend their day worrying about payroll, compliance, licensing, accounting, operations and infrastructure. That is what I want people to understand about Executive Partner."

And at NEXA, the designation is meant to feel earned because the Executive Partner structure is designed to provide extraordinary economics and benefits commensurate with extraordinary contribution, including opportunities for seven-figure income, access to NEXA's private physician and longevity resources for leaders operating at the highest level, and distinctive cultural traditions reserved for those who reach the position.

Among them is perhaps the most uniquely NEXA symbol of all: a rocking chair at Midnight Canyon, NEXA's ranch. It represents something much bigger than a perk, it represents a permanent seat at the table.

Growth Without Ego

The leadership transition comes as NEXA continues expanding its platform, compensation models, technology, servicing opportunities, strategic partnerships and ability to bring established mortgage organizations into its ecosystem.

Farr will now be responsible for ensuring the organization has the operational strength to support that growth while Kortas and NEXA's Executive Partners will be responsible for creating more of it.

"We are building a company where the CEO does not have to be the loudest person in the room, the founder does not have to protect a title, and incredibly successful entrepreneurs do not have to disappear when they become part of something bigger," Farr said. "Everybody should be operating where they create the most value. That is what this structure accomplishes."

For Kortas, that philosophy ultimately comes back to the same constituency around which NEXA has built nearly every major decision: the loan officer.

"If removing my title helps us grow faster, I will remove the title," Kortas said. "If putting Geri in the CEO seat makes NEXA better, she gets the seat. If partnering with somebody who used to compete with me creates more opportunity for our loan officers, I will drop my ego and partner with them, none of this is supposed to be about us, it is supposed to be about the loan officer."

With Farr leading NEXA's execution and its Executive Partners focused on innovation, acquisition, expansion and new economic opportunities, NEXA is not simply changing who holds the CEO title, it is defining what leadership looks like for the company's next era of growth.

SOURCE NEXA Lending

Share this article

Milestone helps bring Iowa's only nuclear energy center back online, strengthen grid reliability and meet growing electricity demand

JUNO BEACH, Fla., Sept. 8, 2026 /PRNewswire/ -- NextEra Energy, Inc. (NYSE: NEE) today announced that it and the U.S. Department of Energy (DOE), through its Office of Energy Dominance Financing (EDF), have reached a combined conditional commitment and financial close on a loan of up to $1.9 billion to support the restart of the company's Duane Arnold Energy Center in Iowa. This milestone moves the company closer to restoring Iowa's only nuclear plant and adding reliable, around-the-clock energy to the regional grid.

The Duane Arnold Energy Center, a 615-megawatt nuclear facility in Linn County, Iowa, is expected to create substantial economic benefits for Iowa and the surrounding region. A study estimated that the restart could generate more than $9 billion in economic benefits for Iowa over 25 years, create thousands of American jobs during construction and refurbishment, support more than 400 permanent high-paying jobs during operations and generate approximately $75 million in tax revenue over the life of the project.

Last October, NextEra Energy announced plans to restart the Duane Arnold Energy Center no later than the first quarter of 2029, pending regulatory approvals. The DOE loan will help NextEra Energy return Duane Arnold to service for its customers, advancing one of the most significant nuclear restart efforts underway in the U.S.

"Restarting Duane Arnold is about delivering new power to meet new demand while generating billions of dollars in economic value for Iowans," said John Ketchum, chairman, president and CEO of NextEra Energy. "Just as importantly, it shows how America can support rapid economic growth and rising electricity demand while helping keep power affordable for existing customers. By bringing new generation online to serve new demand, we can strengthen the grid, create hundreds of good-paying jobs and help ensure Iowa families and businesses are not asked to bear the costs of growth. We appreciate the Administration's leadership in advancing America's nuclear renaissance and share its commitment to an all-of-the-above energy strategy that expands supply, strengthens energy security and keeps America competitive."

"President Trump has set an ambitious course to restore American nuclear leadership, and the restart of Duane Arnold Nuclear Plant in Iowa marks another step in advancing America's nuclear renaissance," said U.S. Deputy Secretary of Energy James P. Danly. "Returning 615 megawatts of reliable baseload generation will drive down electricity costs, while supporting thousands of American jobs. This Administration is pursuing a comprehensive nuclear strategy, restarting existing reactors, increasing the output of our nuclear fleet, and accelerating new construction, to build the abundant, affordable, and reliable power system required for American prosperity and reindustrialization."

"This commitment from the Administration further demonstrates the importance of the Duane Arnold restart and future nuclear development," said Iowa Gov. Kim Reynolds. "I was proud to sign a bill that will provide incentives for nuclear power development, which will put Iowa in the forefront of innovation in the industry. New nuclear development and the restart of Duane Arnold will meet our growing energy demand while also providing hundreds of good-paying jobs throughout the state."

More about Duane Arnold Energy Center

The Duane Arnold Energy Center operated safely and reliably for more than four decades before ceasing operations in 2020. NextEra Energy is pursuing the restart through a comprehensive regulatory, operational readiness and licensing process. Under the oversight of the U.S. Nuclear Regulatory Commission and other federal, state and local agencies, the company continues to conduct extensive inspections, engineering evaluations and readiness activities. In June, the Iowa Utilities Commission issued a certificate to NextEra Energy authorizing the construction and operation of Duane Arnold — another important milestone toward restarting the plant.

About NextEra Energy

NextEra Energy, Inc. (NYSE: NEE) is the largest electric power and energy infrastructure company in North America, the world's leader in renewables and storage and a leading provider of electricity to American homes and businesses. Headquartered in Juno Beach, Florida, NextEra Energy is a Fortune 200 company that owns Florida Power & Light Company, America's largest electric utility, which provides reliable electricity to approximately 12 million people across Florida. NextEra Energy also owns the largest energy infrastructure development company in the U.S., NextEra Energy Resources, LLC. NextEra Energy and its affiliated entities are meeting America's growing energy needs with a diverse mix of energy sources, including renewables, battery storage, nuclear and natural gas. For more information about NextEra Energy companies, visit these websites: www.NextEraEnergy.com, www.FPL.com, www.NextEraEnergyResources.com.

Cautionary Statements and Risk Factors That May Affect Future Results

This news release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but instead represent the current expectations of NextEra Energy, Inc. (together with its subsidiaries, NextEra Energy) regarding future operating results and other future events, many of which, by their nature, are inherently uncertain and outside of NextEra Energy's control. Forward-looking statements in this news release include, among others, statements concerning future financing activities and statements concerning growth strategies, capital investment opportunities and technology initiatives. In some cases, you can identify the forward-looking statements by words or phrases such as "will," "may result," "expect," "anticipate," "believe," "intend," "plan," "seek," "potential," "projection," "forecast," "predict," "goals," "target," "outlook," "should," "would" or similar words or expressions. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance. The future results of NextEra Energy and its business and financial condition are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, or may require it to limit or eliminate certain operations. These risks and uncertainties include, but are not limited to, those discussed in this news release and the following: effects of extensive regulation of NextEra Energy's business operations; inability of NextEra Energy to recover in a timely manner any significant amount of costs, a return on certain assets or a reasonable return on invested capital through base rates, cost recovery clauses, other regulatory mechanisms or otherwise; impact of political, regulatory, operational and economic factors on regulatory decisions important to NextEra Energy; effect of any reductions or modifications to, or elimination of, governmental incentives or policies that support clean energy or changes in or the imposition of additional tax laws, tariffs, duties, policies or other costs or assessments on clean energy or equipment necessary to generate, store or deliver it; impact of new or revised laws, regulations, executive orders, interpretations or constitutional ballot and regulatory initiatives on NextEra Energy; capital expenditures, increased operating costs and various liabilities attributable to environmental laws, regulations and other standards applicable to NextEra Energy; effects on NextEra Energy of federal or state laws or regulations mandating new or additional limits on the production of greenhouse gas emissions; exposure of NextEra Energy to significant and increasing compliance costs and substantial monetary penalties and other sanctions as a result of extensive federal, state and local government regulation of its operations and businesses; effect on NextEra Energy of changes in tax laws, guidance or policies as well as in judgments and estimates used to determine tax-related asset and liability amounts; impact on NextEra Energy of adverse results of litigation; impacts of NextEra Energy of allegations of violations of law; effect on NextEra Energy of failure to proceed with projects under development or inability to complete the construction of (or capital improvements to) electric generation, storage, transmission and distribution facilities, natural gas and oil production and transportation facilities and other facilities on schedule or within budget; impact on development and operating activities of NextEra Energy resulting from risks related to project siting, construction, permitting, governmental approvals and the negotiation of project development agreements, as well as supply chain disruptions; risks involved in the operation and maintenance of electric generation, storage, transmission and distribution facilities, natural gas and oil production and transportation facilities, and other facilities; effect on NextEra Energy of a lack of growth, slower growth or a decline in the number of customers or in customer usage; planned productivity increases and competitive advantages through the use of artificial intelligence technologies may not be realized and the use of and reliance on artificial intelligence may present certain risks; impact on NextEra Energy of severe weather and other weather conditions; threats of terrorism and catastrophic events that could result from geopolitical factors, terrorism, cyberattacks or other attempts to disrupt NextEra Energy's business or the businesses of third parties; inability to obtain adequate insurance coverage for protection of...

Quantinuum conclut un accord de 100 millions de dollars avec le département américain du Commerce dans le cadre du programme CHIPS R&D pour soutenir la fabrication d'ordinateurs quantiques à ions piégés aux États-Unis

- Ce financement fédéral soutient les activités essentielles de R&D ainsi que les capacités de fabrication américaines de semiconducteurs quantiques nécessaires au développement à grande échelle de l'informatique quantique à ions piégés tolérante aux pannes.

- L'entreprise s'associe à GlobalFoundries pour fabriquer des pièges ioniques et des composants électroniques de contrôle de nouvelle génération, ainsi qu'à Monarch Quantum pour développer et fabriquer des lasers et des composants optiques fiables.

WASHINGTON, 8 septembre 2026 /PRNewswire/ -- Quantinuum (Nasdaq : QNT), une entreprise de premier plan dans le domaine de l'informatique quantique, annonce aujourd'hui avoir conclu un accord avec le CHIPS Research and Development Office du département américain du Commerce, portant sur un financement fédéral de 100 millions de dollars octroyé dans le cadre du CHIPS and Science Act. Cette subvention, qui fait suite à une lettre d'intention annoncée en mai, soutient la R&D et les capacités de fabrication américaines de semiconducteurs quantiques nécessaires au déploiement d'ordinateurs quantiques à ions piégés à grande échelle et tolérants aux pannes.

Quantinuum, seule entreprise dotée d'une architecture basée sur les ions piégés à avoir obtenu un financement CHIPS R&D, développe les ordinateurs quantiques commerciaux les plus précis au monde[1], dotés d'une fidélité de correction d'erreurs à la pointe du secteur.[2] L'entreprise s'appuie sur des procédés de fabrication de semiconducteurs éprouvés pour garantir la fiabilité, la répétabilité et l'évolutivité de ses ordinateurs quantiques actuels et futurs.

« Ce prix vient confirmer le leadership de Quantinuum dans le domaine de l'informatique quantique à ions piégés », déclare Rajeeb Hazra, président et CEO de Quantinuum. « En collaboration avec nos partenaires nationaux, nous mettons en place les bases technologiques et logistiques nécessaires pour développer à grande échelle des systèmes tolérants aux pannes et renforcer le leadership des États-Unis dans ce domaine d'importance stratégique. »

Cette subvention permettra de soutenir les activités de R&D qui, selon l'entreprise, contribueront à renforcer et à diversifier sa chaîne d'approvisionnement, en y intégrant les partenaires nationaux GlobalFoundries et Monarch Quantum. GlobalFoundries fera partie des fonderies sélectionnées par Quantinuum pour fabriquer ses pièges à ions de nouvelle génération et d'autres composants électroniques, en mettant particulièrement l'accent sur l'utilisation de la technologie des plaquettes de 300 mm ; Monarch Quantum prévoit de développer et de fabriquer des lasers et des composants optiques évolutifs et fiables, nécessaires aux systèmes à ions piégés de Quantinuum.

« À mesure que l'informatique quantique se rapproche d'une échelle commerciale, la fabrication jouera un rôle crucial pour exploiter pleinement son potentiel », déclare Tim Breen, CEO de GlobalFoundries. « GlobalFoundries est fier de s'associer à Quantinuum pour contribuer au développement de sa technologie des ions piégés. Grâce à notre expertise dans la fabrication de semiconducteurs différenciés à grande échelle, nous contribuons à ouvrir la voie à du matériel quantique plus évolutif et plus fiable, et à faire progresser la prochaine génération d'innovations américaines. »

« Pour parvenir à des ordinateurs quantiques à ions piégés à grande échelle, il faut abandonner les dispositifs optiques complexes et encombrants au profit de moteurs photoniques intégrés, évolutifs et fiables », déclare Timothy Day, CEO de Monarch Quantum. « Nous sommes honorés de renforcer notre partenariat avec Quantinuum afin de faire progresser sa feuille de route en matière de matériel et de contribuer à consolider le leadership des États-Unis dans la fabrication d'ordinateurs quantiques et la résilience de la chaîne d'approvisionnement. »

Ensemble, ces efforts visent à réduire la complexité du système et à améliorer la robustesse, la fiabilité et la reproductibilité des composants, afin de soutenir à terme la poursuite de la mise à l'échelle des ordinateurs quantiques à ions piégés, tout en renforçant les capacités nationales dans les domaines critiques de la photonique et de la fabrication de semiconducteurs.

À propos de Quantinuum

Quantinuum est une société d'informatique quantique de premier plan qui propose une plateforme complète conçue pour permettre le déploiement de l'informatique quantique dans des environnements réels. La société a commercialisé plusieurs générations de systèmes quantiques à ions piégés, basés sur l'architecture QCCD bien établie, qu'elle a mise en œuvre avec des conceptions et des capacités innovantes afin d'atteindre les niveaux de précision les plus élevés du secteur, sur la base d'une fidélité moyenne des portes à deux qubits.[3] Quantinuum collabore activement avec des leaders du marché dans les secteurs pharmaceutique, des sciences des matériaux, des services financiers, ainsi qu'avec les marchés publics et industriels, sans oublier les établissements universitaires et de recherche du monde entier. L'entreprise emploie plus de 800 personnes dans le monde, dont des scientifiques et des chercheurs de haut niveau. Le siège de Quantinuum est situé à Broomfield, dans le Colorado, et la société possède d'autres installations aux États-Unis, au Royaume-Uni, en Allemagne, au Japon, au Qatar et à Singapour. Pour plus d'informations, veuillez consulter www.quantinuum.com

Mise en garde concernant les déclarations prospectives

Le présent communiqué de presse contient certaines déclarations qui peuvent être considérées comme des « déclarations prospectives » au sens du Private Securities Litigation Reform Act de 1995. Les déclarations prospectives comprennent toutes les déclarations qui ne sont pas des faits historiques. Les mots « anticiper », « supposer », « croire », « continuer », « pouvoir », « estimer », « s'attendre à », « avoir l'intention », « être susceptible de », « planifier », « potentiel », « prédire », « projeter », « futur », « chercher », « prévisible », la version négative de ces mots, ou des termes et expressions similaires ont pour but d'identifier les déclarations prospectives. Ces déclarations reposent sur certaines hypothèses et évaluations faites par notre direction à la lumière de son expérience et de sa perception des tendances historiques, des conditions économiques et sectorielles actuelles, des développements futurs attendus et d'autres facteurs qu'elle juge appropriés. Les déclarations prospectives figurant dans le présent communiqué sont également soumises à un certain nombre de risques et d'incertitudes, y compris, mais sans s'y limiter, des facteurs économiques, concurrentiels, gouvernementaux et technologiques affectant nos activités, nos marchés, nos produits, nos services et nos prix. De nouveaux facteurs apparaissent de temps à autre, que Quantinuum ne peut pas tous prévoir. Pour plus d'informations sur ces risques et d'autres risques susceptibles d'avoir une incidence sur les déclarations prospectives de Quantinuum, veuillez vous reporter aux facteurs de risque de Quantinuum présentés dans ses documents déposés auprès de la Securities and Exchange Commission des États-Unis, notamment son rapport trimestriel sur le formulaire 10-Q pour la période close le 30 juin 2026, ces facteurs de risque pouvant faire l'objet de mises à jour ponctuelles. Toute déclaration prospective n'est valable qu'à la date de sa publication et, sauf si la loi l'exige, Quantinuum ne s'engage à assumer aucune obligation de mise à jour ou de révision d'une déclaration prospective, que ce soit à la suite de nouvelles informations, d'événements futurs ou autres.

[1] Sur la base de la fidélité physique des portes à deux qubits au 31 décembre 2025, selon la Ransford et al. study de 2025.

[2] Au 25 février 2026, selon la Dasu et al. study de 2026.

[3] Au 31 décembre 2025.

Share this article

First OX40 agonist to demonstrate clinical benefit in a randomized study

- INBRX-106 plus pembrolizumab delivers a 48.3% cORR and 72.4% of patients remain progression free at 6 months, compared with 26.5% and 42.8% for pembrolizumab alone

- Results are most pronounced in HPV+ patients, with cORR (80.0% vs 33.3%), CR rate (30.0% vs 0%), and PFS6 improvement (90.0% vs 33.0%) vs pembrolizumab alone

- Inhibrx will expand the Phase 2 study by approximately 50 HPV+ patients and may serve as a potential pathway to accelerated approval

- Positive results support large expansion opportunities into highly immunogenic tumors and combination with cancer vaccines

SAN DIEGO, Sept. 8, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates, today announced the primary endpoint results from the randomized and controlled Phase 2 portion of the HexAgon study, which is evaluating the safety and efficacy of INBRX-106, a hexavalent OX40 agonist, in combination with pembrolizumab (the combination arm) versus pembrolizumab monotherapy (the control arm) in first-line patients with treatment-naïve, PD-L1 positive (CPS ≥ 20) metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC). Baseline prognostic factors were largely balanced between the two arms, and the study is being conducted at more than 80 sites in the United States, Europe and Asia. The Phase 2 portion of the HexAgon study included a total of 68 randomized patients, 63 of whom were evaluable for the primary endpoint analysis, including 29 patients in the combination arm (10 of which were HPV+) and 34 patients in the control arm (nine of which were HPV+).

The primary endpoint analysis, which had a data cutoff of August 19, 2026, demonstrated a confirmed objective response rate (cORR) of 48.3% for INBRX-106 plus pembrolizumab compared with 26.5% for pembrolizumab alone. Four patients (13.8%) in the combination arm achieved a complete response compared with no complete responses in the control arm. Median progression-free survival (PFS) continues to mature. As of the data cutoff, median PFS was 9.6 months for INBRX-106 plus pembrolizumab compared with 4.9 months for pembrolizumab alone, with six-month PFS rates of 72.4% and 42.8%, respectively.

The efficacy signal was particularly pronounced in patients with HPV+ disease, where the combination arm demonstrated an 80.0% cORR compared with 33.3% for pembrolizumab alone. Notably, 30.0% of the HPV+ patients treated in the combination arm achieved a complete response, compared with no complete responses in the control arm. The durability of the benefit was also particularly striking, with 90.0% of patients receiving INBRX-106 plus pembrolizumab remaining progression-free at six months compared with 33.0% who were receiving pembrolizumab alone. As of the data cutoff, median PFS in the combination arm in patients with HPV+ disease had not yet been reached compared with 4.6 months for pembrolizumab alone.

The combination of INBRX-106 and pembrolizumab was generally manageable. The most common treatment-related adverse events were rash, fatigue, and diarrhea, which were predominantly low grade.

"What is most exciting to us is the depth and durability of the responses we are seeing with INBRX-106, particularly in HPV+ disease," said Mark Lappe, co-founder and Chief Executive Officer of Inhibrx. "These results strengthen our conviction in OX40-mediated T-cell costimulation and give us a strong rationale to expand the program, not only into HPV+ disease, but also to explore the potential of INBRX-106 in other highly immunogenic tumors and in combination with cancer vaccines."

Based on these results, Inhibrx plans to expand the randomized Phase 2 portion of the HexAgon trial by approximately 50 additional HPV+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) patients (CPS ≥ 1), to support a potential accelerated regulatory pathway. Following the Phase 2 expansion, the Company plans to align with the FDA on this framework and initiate the Phase 3 portion of the HexAgon trial, which is intended to serve as the confirmatory study. These results also position OX40 agonism as a promising treatment approach beyond recurrent/metastatic disease, with potential to extend durable, T-cell driven antitumor activity into earlier-stage HPV+ OPSCC.

Beyond HNSCC, Inhibrx is evaluating the potential of INBRX-106 in other highly immunogenic tumor types. The Company is currently conducting a Phase 1/2 study of INBRX-106 in the perioperative setting of non-small cell lung cancer (NSCLC), with initial results targeted by mid-2027. This readout is expected to provide important clinical insights to inform future development, demonstrating the potential for INBRX-106 to extend well beyond head and neck cancer into not only perioperative lung cancer, but broader solid tumor indications.

The Company also plans to explore the potential of INBRX-106 in combination with therapeutic cancer vaccines. The clinical activity and T-cell responses observed with INBRX-106 in HPV+ disease demonstrate its ability to amplify antigen-driven T-cell responses, providing strong scientific justification for cancer vaccine combination strategies.

The Company will host a live webcast presentation today, September 8, 2026, at 5:00 a.m. Pacific Time to further discuss the results. The webcast will also include a slide presentation of the data, which is also incorporated into the Company's investor deck accessible at https://inhibrx.com/inhibrx-biosciences-inc-investors/.

About the Conference Call

Investors may join via the web: https://app.webinar.net/4712m15mpwW or may listen to the call by dialing (1-888-880-3330). Please refer to Inhibrx Biosciences, Inc. or the conference ID 6981384 when calling in. The webcast will also include a slide presentation of the data, which is also incorporated into the Company's investor deck accessible at https://inhibrx.com/inhibrx-biosciences-inc-investors/. Following the webcast, the presentation may be accessed through a link on the "Events and Presentations" section of Inhibrx's website. The webcast will be available for 60 days following the event. Inhibrx will also update its corporate presentation within the "Investors" section of its website at www.inhibrx.com.

About INBRX-106

INBRX-106 is a hexavalent agonist targeting OX40 (CD134), a costimulatory receptor on T-cells. Utilizing Inhibrx's proprietary single-domain antibody (sdAb) platform, INBRX-106 is designed to achieve the high-order receptor clustering necessary for robust T-cell activation and survival, a feat that has eluded traditional bivalent antibody approaches.

About Inhibrx Biosciences, Inc.

Inhibrx Biosciences is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx Biosciences utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms. Inhibrx Biosciences was incorporated in January 2024 as a direct, wholly-owned subsidiary of Inhibrx, Inc. Prior to the sale of Inhibrx, Inc. and the INBRX-101 program to Sanofi S.A., Inhibrx Biosciences acquired certain corporate infrastructure and other assets and liabilities through a series of internal restructuring transactions effected by Inhibrx, Inc. Inhibrx, Inc. also completed a distribution to holders of its shares of common stock of 92% of the issued and outstanding shares of Inhibrx Biosciences. Following such transactions, Inhibrx Biosciences' current clinical pipeline of therapeutic candidates includes ozekibart (INBRX-109) and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what we believe to be the most appropriate agonist function. For more information, please visit www.inhibrx.com.

Forward-Looking Statements

Inhibrx cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on Inhibrx's current beliefs and expectations. These forward-looking statements include, but are not limited to, statements regarding: Inhibrx's judgments and beliefs regarding the strength of Inhibrx's pipeline; statements regarding the safety and efficacy of its therapeutic candidate, INBRX-106, based on topline and interim results; the potential for INBRX-106 to be used for the treatment of HNSCC or other indications; the clinical development of INBRX-106, including expected enrollment in an expansion cohort, data readouts, initiation of additional clinical trials, regulatory submissions and interactions, and the timing thereof; the potential accelerated approval; any presumption that topline, interim or preliminary data will be representative of final data or data in later clinical trials; and Inhibrx's plans to evaluate INBRX-106 across broader indications and to explore combinations with other therapies.

Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US

- The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.

- Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch Quantum to develop and manufacture reliable lasers and optical components.

WASHINGTON, Sept. 8, 2026 /PRNewswire/ -- Quantinuum (Nasdaq: QNT), a leading quantum computing company, today announced it has finalized an agreement with the U.S. Department of Commerce's CHIPS Research and Development Office for $100 million in federal funding deployed through the CHIPS and Science Act. The award, which follows a letter of intent announced in May, supports R&D and U.S. quantum semiconductor manufacturing capabilities needed to deploy large-scale, fault-tolerant trapped-ion quantum computers.

Quantinuum, which was the only company with a trapped-ion based architecture to be awarded CHIPS R&D funding, develops the world's most accurate commercial[1] computers with industry-leading error correction fidelity.[2] The company leverages established semiconductor manufacturing processes to help ensure reliability, repeatability, and scalability of the company's current and future quantum computers.

"This award is a validation of Quantinuum's leadership in trapped-ion quantum computing," said Dr. Rajeeb Hazra, President and CEO of Quantinuum. "Together with our domestic partners, we are building the technology and supply-chain foundation needed to scale fault-tolerant systems and strengthen America's leadership in this strategically important field."

The award will support R&D that the company expects to help strengthen and diversify its supply chain, adding onshore partners GlobalFoundries and Monarch Quantum. GlobalFoundries will be one of several of Quantinuum's foundries enlisted to fabricate its next-generation ion traps and other electronics, specifically focused on using 300mm wafer technology; Monarch Quantum plans to develop and manufacture scalable, reliable lasers and optical components required for Quantinuum's trapped-ion systems.

"As quantum computing moves closer to commercial scale, manufacturing will be critical to unlocking its full potential," said Tim Breen, CEO of GlobalFoundries. "GlobalFoundries is proud to partner with Quantinuum to help scale their trapped-ion technology. By bringing our expertise in high-volume, differentiated semiconductor manufacturing, we're helping create a path to more scalable, reliable quantum hardware and advancing the next generation of American innovation."

"The road to large-scale, trapped-ion quantum computers relies on moving away from complex, sprawling optical setups to scalable, reliable integrated photonics engines," said Dr. Timothy Day, CEO of Monarch Quantum. "We are honored to expand our partnership with Quantinuum to advance their hardware roadmap and to help strengthen U.S. leadership in quantum computing manufacturing and supply chain resilience."

Together, these efforts are intended to reduce system complexity and improve component robustness, reliability, and reproducibility, ultimately supporting the continued scaling of trapped-ion quantum computers, while strengthening domestic capability across critical photonics and semiconductor manufacturing.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry's highest accuracy levels based on average two-qubit gate fidelity.[3] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of over 800 employees, including top scientists and researchers. Quantinuum's headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain statements that may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. For additional information on these and other risks that could affect Quantinuum's forward-looking statements, see Quantinuum's risk factors discussed in its filings with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the period ended June 30, 2026, as such risk factors may be updated from time to time. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

[1] Based on physical two-qubit gate fidelity as of December 31, 2025, according to the 2025 Ransford et al. study.

[2] As of February 25, 2026, according to the 2026 Dasu et al. study.

[3] As of December 31, 2025.

SOURCE Quantinuum

Share this article

RESTON, Va., Sept. 8, 2026 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) today announced it has been awarded a $19 million indefinite-delivery/indefinite-quantity contract by the U.S. Marine Corps to deliver Tempest counter-Unmanned Aerial System (C-UAS) vehicles, expanding access to a highly mobile capability designed to protect maneuver forces against rapidly evolving unmanned threats.

Under the contract, V2X will provide Tempest vehicles along with maintenance support, software management, spares, ancillary components, training, and other associated engineering services. Designed for speed, mobility, and adaptability, Tempest provides maneuver forces with a rapidly deployable solution capable of detecting, tracking, and defeating unmanned aerial threats while maintaining the flexibility to reposition as mission requirements evolve.

"Unmanned aerial systems are fundamentally changing the modern battlefield, creating an urgent need for counter-UAS solutions that are mobile, effective, and ready to operate in demanding environments," said Jeremy C. Wensinger, President and Chief Executive Officer of V2X. "Tempest demonstrates what V2X does exceptionally well: respond to an urgent customer need and rapidly take a capability from concept and integration through fielding and sustainment. By bringing together our engineering, technology integration, logistics, and mission expertise, we can move with speed to deliver mission-ready solutions that directly address emerging threats."

Tempest was developed by V2X as a highly mobile counter-UAS solution capable of operating alongside maneuver forces in austere and contested environments. Its commercially derived architecture enables rapid deployment, sustainment, and adaptability while providing the mobility required to respond to dynamic threats.

The award further strengthens V2X's growing counter-UAS portfolio and demonstrates the company's ability to develop, integrate, field, and sustain solutions in response to evolving operational requirements. V2X combines engineering, technology integration, logistics, training, and mission expertise to accelerate capability from concept to the field.

About V2X

V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission's lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today's toughest challenges across all operational domains.

Investor Contact

Mike Smith, CFA

Vice President, Treasury, Corporate Development and Investor Relations

[email protected] 

719-637-5773

Media Contact

Angelica Spanos Deoudes

Senior Director, Marketings and Communications

[email protected]

571-338-5195

SOURCE V2X, Inc.

Share this article